Trendlines Medical portfolio company Gordian Surgical said today it raised nearly $1 million in a new round of funding joined by Chinese venture capital firm Virtus Inspire Ventures.
Gordian is developing a trocar device that inserts sutures into tissue surrounding incisions at the beginning of a procedure and anchors them in place throughout the operation, the company said.
“I am extremely pleased by the growing level of interest in our company and technology. This investment by a VC and senior surgeons is evidence of the confidence in our team and in the market potential of our products,” Gordian Surgical CEO Zvi Pe’er said in a press release.
The company did not say who led the round, but said it was joined by a number of leading U.S. laparoscopic surgeons and other investors.
“We are very proud of Gordian’s progress as a company that is developing a simple, cost-saving trocar to reduce the risks and complications of laparoscopic procedures and has attracted global interest from investors and industry leaders,” Trendlines Medical CEO Eran Feldhay said in prepared remarks.
In September, Trendlines portfolio company Elastimed said it raised $1 million to support its development of ‘smart’ compression stockings.
The Israel-based company is developing a wearable smart material stocking to treat chronic venous insufficiency and prevent deep venous thrombosis, according to a press release.